Back to Awarded Treatment Trials


Awarded Trial: 14T-011

Grant ID

14T-011

Illness

Bipolar disorder

Primary Drug/Intervention

Cannabidiol

Primary Dosage

200-400 mg

Secondary Drug Intervention

mood stabilizer and/or antipsychotic drug treatment

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Preparing to start

Investigator

Rentzsch

Sample Size

82

Duration of Study Period for Each Subject

56 days

Outcome Measurements

Primary efficacy endpoint: Decline in Hamilton Rating Scale for Depression (HDRS) score from baseline to week 8

Results

N/A

Publication

N/A

Link

N/A

PI Name

Johannes Rentzsch

Degree

MD

Center

N/A

Institution

Charite-Universitatsmedizin Berlin

Address

Chariteplatz 1

City or Town

Berlin

State or Province

N/A

Zip or Postal Code

10117

Country

Germany

Email Address

johannes.retzsch@charite.de